2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE

Modify Date: 2024-01-08 18:08:28

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure
2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE structure
Common Name 2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE
CAS Number 852-38-0 Molecular Weight 298.33800
Density 1.172g/cm3 Boiling Point 480.7ºC at 760 mmHg
Molecular Formula C20H14N2O Melting Point 167-169 °C(lit.)
MSDS Chinese USA Flash Point 240.7ºC

 Use of 2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE


2-(4-Biphenylyl)-5-phenyl-1,3,4-oxadiazole is a laser dyes with high photoluminescence (PL) quantum efficiency[1].

 Names

Name 2-(4-Biphenylyl)-5-phenyl-1,3,4-oxadiazole
Synonym More Synonyms

  Biological Activity

Description 2-(4-Biphenylyl)-5-phenyl-1,3,4-oxadiazole is a laser dyes with high photoluminescence (PL) quantum efficiency[1].
Related Catalog
References

[1]. Wang C, et al. Polymeric Alkoxy PBD [2-(4-Biphenylyl)-5-Phenyl-1, 3, 4-Oxadiazole] for Light-Emitting Diodes. Advanced Functional Materials, 2001, 11(1): 47-50.

 Chemical & Physical Properties

Density 1.172g/cm3
Boiling Point 480.7ºC at 760 mmHg
Melting Point 167-169 °C(lit.)
Molecular Formula C20H14N2O
Molecular Weight 298.33800
Flash Point 240.7ºC
Exact Mass 298.11100
PSA 38.92000
LogP 5.07060
Index of Refraction 1.612
Storage condition 2-8°C

 MSDS

Name: Pbd Scintillation Grade Material Safety Data Sheet
Synonym: 1,3,4-Oxodiazole,2-1,1'-Biphenyl-4-yl-5-Pheny
CAS: 852-38-0
Section 1 - Chemical Product MSDS Name:Pbd Scintillation Grade Material Safety Data Sheet
Synonym:1,3,4-Oxodiazole,2-1,1'-Biphenyl-4-yl-5-Pheny

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
852-38-0 1,3,4-Oxadiazole, 2-1,1'-Biphenyl-4-yl ca 100 212-712-0
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 852-38-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 168.00 - 170.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C20H14N2O
Molecular Weight: 298.33

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 852-38-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
1,3,4-Oxadiazole, 2-1,1'-Biphenyl-4-yl-5-Phenyl - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 852-38-0: No information available.
Canada
CAS# 852-38-0 is listed on Canada's NDSL List.
CAS# 852-38-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 852-38-0 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes Xi
Safety Phrases S22-S24/25
RIDADR NONH for all modes of transport
WGK Germany 3
HS Code 2934999090

 Synthetic Route

~85%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Majji, Ganesh; Rout, Saroj Kumar; Guin, Srimanta; Gogoi, Anupal; Patel, Bhisma K. RSC Advances, 2014 , vol. 4, # 11 p. 5357 - 5362

~82%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Wang, Ying; Sauer, Daryl R.; Djuric, Stevan W. Tetrahedron Letters, 2006 , vol. 47, # 1 p. 105 - 108

~66%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Milcent, Rene; Barbier, Geo Journal of Heterocyclic Chemistry, 1983 , vol. 20, p. 77 - 80

~%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Journal of the American Chemical Society, , vol. 77, p. 1850

~%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Journal of the American Chemical Society, , vol. 77, p. 1850

~%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Journal of the American Chemical Society, , vol. 77, p. 1850

~%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Tetrahedron, , vol. 62, # 43 p. 10223 - 10236

~%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Magnetic Resonance in Chemistry, , vol. 49, # 10 p. 648 - 654

~%

2-(4-BIPHENYLYL)-5-PHENYL-1,3,4-OXADIAZOLE Structure

2-(4-BIPHENYLYL...

CAS#:852-38-0

Literature: Magnetic Resonance in Chemistry, , vol. 49, # 10 p. 648 - 654

 Customs

HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Articles29

More Articles
Cytohesin 2/ARF6 regulates preadipocyte migration through the activation of ERK1/2.

Biochem. Pharmacol. 92(4) , 651-60, (2015)

Preadipocyte migration is vital for the development of adipose tissue, which plays a crucial role in lipid metabolism. ADP-ribosylation factor 6 (ARF6) small GTPase, which regulates membrane trafficki...

mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis.

PLoS Genet. 11 , e1005291, (2015)

Akt phosphorylation is a major driver of cell survival, motility, and proliferation in development and disease, causing increased interest in upstream regulators of Akt like mTOR complex 2 (mTORC2). W...

Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge.

PLoS ONE 9(10) , e111534, (2014)

Chemotaxis is controlled by interactions between receptors, Rho-family GTPases, phosphatidylinositol 3-kinases, and cytoskeleton remodeling proteins. We investigated how the metastasis suppressor, SSe...

 Synonyms

EINECS 212-712-0
2-phenyl-5-(4-phenylphenyl)-1,3,4-oxadiazole
MFCD00003100